Before the start of the conference call the earnings call presentation will be available on the company's website Investor section. The presentation will be held in English.
Date: Thursday, February 25, 2021. 14:00 (CET)
For audio: +46 8 502 439 36 Conference ID: 888 731 010#
For video: Video link to the presentation.
Participants from CELLINK: Erik Gatenholm, CEO and Gusten Danielsson, CFO
Please note for the Q&A session you have two options: a) if you join via audio you can ask questions directly to the presenters b) if you join via video you can only use the chat function to ask questions.
For further information, please contact:
Isabelle Ljunggren, Head of Communications
Phone: +46 70 830 08 90 or +46 73 518 15 59
Email: [email protected]
Founded in 2016, CELLINK is the leading bioconvergence company in world that provides technologies, products and services to create, understand and master biology. With a focus on the application areas of bioprinting, multiomics, cell line development, and diagnostics, the company develops and markets innovative technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical and cosmetic industries. CELLINK’s products are trusted by more than 1,800 laboratories, including ones at all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than
700 publications. CELLINK is creating the future of medicine. Visit cellink.com to learn more. CELLINK is listed on the Nasdaq Stockholm under CLNK B.